GPT Healthcare Ltd
Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services[1]
- Market Cap ₹ 1,063 Cr.
- Current Price ₹ 130
- High / Low ₹ 185 / 123
- Stock P/E 26.2
- Book Value ₹ 30.9
- Dividend Yield 1.94 %
- ROCE 27.2 %
- ROE 21.3 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 67.9%
Cons
- Promoter holding has decreased over last 3 years: -34.4%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 212 | 243 | 337 | 361 | 400 | 407 | 448 | |
| 176 | 194 | 263 | 287 | 312 | 324 | 366 | |
| Operating Profit | 36 | 49 | 74 | 74 | 88 | 83 | 82 |
| OPM % | 17% | 20% | 22% | 21% | 22% | 20% | 18% |
| 4 | 6 | 5 | 6 | 5 | 8 | 6 | |
| Interest | 14 | 14 | 11 | 9 | 7 | 3 | 7 |
| Depreciation | 11 | 12 | 14 | 15 | 18 | 19 | 25 |
| Profit before tax | 15 | 29 | 54 | 56 | 68 | 69 | 55 |
| Tax % | 26% | 27% | 23% | 30% | 30% | 28% | |
| 11 | 21 | 42 | 39 | 48 | 50 | 41 | |
| EPS in Rs | 6.11 | 11.76 | 5.21 | 4.88 | 5.82 | 6.08 | 4.94 |
| Dividend Payout % | 0% | 47% | 0% | 102% | 60% | 41% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 6% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 35% |
| 3 Years: | 6% |
| TTM: | -19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 23% |
| Last Year: | 21% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 80 | 80 | 82 | 82 | 82 |
| Reserves | 109 | 116 | 78 | 85 | 136 | 166 | 172 |
| 157 | 166 | 102 | 82 | 31 | 35 | 97 | |
| 25 | 18 | 63 | 79 | 96 | 101 | 113 | |
| Total Liabilities | 308 | 317 | 323 | 327 | 346 | 384 | 463 |
| 226 | 220 | 220 | 228 | 224 | 228 | 342 | |
| CWIP | 2 | 0 | 1 | 3 | 6 | 46 | 2 |
| Investments | 1 | 1 | 10 | 13 | 30 | 32 | 32 |
| 80 | 97 | 92 | 83 | 85 | 78 | 87 | |
| Total Assets | 308 | 317 | 323 | 327 | 346 | 384 | 463 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 41 | 43 | 66 | 66 | 69 | 67 | |
| -54 | -16 | -5 | 5 | -25 | -33 | |
| 12 | -22 | -57 | -73 | -48 | -35 | |
| Net Cash Flow | -1 | 4 | 3 | -2 | -5 | -0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 30 | 26 | 15 | 21 | 22 | 18 |
| Inventory Days | 60 | 41 | 30 | 43 | 36 | 41 |
| Days Payable | 314 | 165 | 121 | 161 | 165 | 161 |
| Cash Conversion Cycle | -224 | -98 | -76 | -97 | -106 | -102 |
| Working Capital Days | -4 | 32 | 3 | -18 | -16 | -28 |
| ROCE % | 14% | 23% | 25% | 30% | 27% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
20h - Uploaded audio of Feb 3, 2026 conference call on Q3 & 9MFY26 results; no unpublished price-sensitive information.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
24h - Copy of News Paper publication of Unaudited Financial Results for the 3rd Quarter ended December 31, 2025.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - Q3 & 9M FY26 results: 9M revenue Rs351cr (+12%); 9M PAT Rs27.6cr (-25%); occupancy 55%.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
1d - Investor Presentation for Q3 9MFY26 ended December 31, 2025.
- Un-Audited Financial Results For The 3Rd Quarter And Nine Months (Q3 & 9MFY26) Ended December 31, 2025 1d
Concalls
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Mar 2024Transcript PPT
Business Overview:[1]
GPT Healthcare Limited operates as a key regional corporate healthcare provider in Eastern India under the ILS Hospitals brand. The organization has established 5 multi-specialty hospitals with a total capacity of 719 beds, supported by 91 full-time consultants and 570 visiting consultants.